[EN] KRAS G12C INHIBITORS<br/>[FR] INHIBITEURS DE KRAS G12C
申请人:MIRATI THERAPEUTICS INC
公开号:WO2020146613A1
公开(公告)日:2020-07-16
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
[EN] CHIRAL-SUBSTITUTED POLY-N-VINYLPYRROLIDINONES AND COMPLEXES WITH BIMETALLIC NANOCLUSTERS AND USES THEREOF IN ASYMMETRIC OXIDATION REACTIONS<br/>[FR] POLY-N-VINYLEPYRROLIDINONES SUBSTITUÉES CHIRALES ET COMPLEXES COMPORTANT DES NANOAGRÉGATS BIMÉTALLIQUES ET LEURS UTILISATIONS DANS DES RÉACTIONS D'OXYDATION ASYMÉTRIQUES
申请人:UNIV KANSAS STATE
公开号:WO2020163295A1
公开(公告)日:2020-08-13
Chiral polyvinylpyrrolidinone (CSPVP), complexes of CSPVP with a core species, such as a bimetallic nanocluster catalyst, and enantioselective oxidation reactions utilizing such complexes are disclosed. The catalytic complexes have exhibited the ability to achieve reaction products have a very high degree of optical purities. These reaction products can be used as reagents in the synthesis of complex organic molecules, such as bioactive products, and C-H bond oxidation of complex molecules including various drugs and natural products.